Click here to visit the official EMN congress website >
Representation from HARMONY’s Multiple Myeloma research team
Researchers from HARMONY's Multiple Myeloma research project will be attending the meeting. The EMN congress provides an excellent opportunity for HARMONY to share its findings with the hematology community.
Read more about how EMN and HARMONY join forces to improve the treatment of myeloma >
The HARMONY platform currently contains anonymized data records from more than 5,500 newly diagnoses patients with Multiple Myeloma. The team has used these data to suggest improvements to the Revised-International Staging System (R-ISS), in order to better predict outcomes in these patients.
Read more about the HARMONY's Research Project in Multiple Myeloma
Read more about the HARMONY Big Data Platform
Click here to visit the official EMN 2020 congress website.
See what other meetings HARMONY is holding and attending by visiting our meetings page.
Become involved with HARMONY today! Contact us to find out how you can participate in ongoing and future research initiatives.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
